259 related articles for article (PubMed ID: 32246150)
1. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
Shi C; Ye Z; Han J; Ye X; Lu W; Ji C; Li Z; Ma Z; Zhang Q; Zhang Y; He W; Chen Z; Cao X; Shou X; Zhou X; Wang Y; Zhang Z; Li Y; Ye H; He M; Chen H; Cheng H; Sun J; Cai J; Huang C; Ye F; Luo C; Zhou B; Ding H; Zhao Y
Neuro Oncol; 2020 Aug; 22(8):1114-1125. PubMed ID: 32246150
[TBL] [Abstract][Full Text] [Related]
2. The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C; Xu W; Ding H; Chen Z; Shi C; Han J; Yu L; Qiao N; Zhang Y; Cao X; Zhou X; Cheng H; Feng H; Luo C; Li Z; Zhou B; Ye Z; Zhao Y
J Clin Endocrinol Metab; 2022 May; 107(6):e2291-e2300. PubMed ID: 35247260
[TBL] [Abstract][Full Text] [Related]
3. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
4. Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
Tucker DW; Pangal DJ; Du R; Gogia AS; Tafreshi A; Ruzevick J; Hurth KT; Triche T; Micko A; Carpten JD; Shiroishi MS; Carmichael JD; Rhie SK; Zada G
PLoS One; 2023; 18(4):e0284949. PubMed ID: 37104368
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive circular RNA profiling reveals that hsa_circ_0001368 is involved in growth hormone-secreting pituitary adenoma development.
Du Q; Zhang W; Feng Q; Hao B; Cheng C; Cheng Y; Li Y; Fan X; Chen Z
Brain Res Bull; 2020 Aug; 161():65-77. PubMed ID: 32389802
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.
Cai F; Chen S; Yu X; Zhang J; Liang W; Zhang Y; Chen Y; Chen S; Hong Y; Yan W; Wang W; Zhang J; Wu Q
Neuro Oncol; 2022 Jun; 24(6):925-935. PubMed ID: 34932801
[TBL] [Abstract][Full Text] [Related]
7. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
[TBL] [Abstract][Full Text] [Related]
8. The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor.
Nie D; Fang Q; Cheng J; Li B; Li M; Wang H; Li C; Gui S; Zhang Y; Zhao P
Cancer Immunol Immunother; 2022 May; 71(5):1233-1245. PubMed ID: 34647152
[TBL] [Abstract][Full Text] [Related]
9. Central Hypothyroidism Related to Pituitary Adenomas: Low Incidence of Central Hypothyroidism in Patients With Acromegaly.
Takamizawa T; Horiguchi K; Nakajima Y; Okamura T; Ishida E; Matsumoto S; Yoshino S; Yamada E; Saitoh T; Ozawa A; Tosaka M; Yamada S; Yamada M
J Clin Endocrinol Metab; 2019 Oct; 104(10):4879-4888. PubMed ID: 31188431
[TBL] [Abstract][Full Text] [Related]
10. Targeting the SPHK1/S1P/S1PR2 axis ameliorates GH-secreted pituitary adenoma progression.
Sun H; Hu B; Wu C; Jiang T
Eur J Clin Invest; 2024 Mar; 54(3):e14117. PubMed ID: 37888843
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.
Pangal DJ; Wishart D; Shiroishi MS; Ruzevick J; Carmichael JD; Zada G
Pituitary; 2022 Jun; 25(3):480-485. PubMed ID: 35334028
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.
An J; Pei X; Zang Z; Zhou Z; Hu J; Zheng X; Zhang Y; He J; Duan L; Shen R; Zhang W; Zhu F; Li S; Yang H
Oncotarget; 2017 Jun; 8(23):37538-37549. PubMed ID: 28380462
[TBL] [Abstract][Full Text] [Related]
13. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
[TBL] [Abstract][Full Text] [Related]
15. Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma.
Wang M; Ji C; Zhang Y; Zhang Z; Zhang Y; Guo H; Qiao N; Zhou X; Cao X; Ye Z; Yu Y; Melnikov V; Gong W; He M; Zhang Z; Zhao Y; Wang X; Wei G; Ye Z
Endocrine; 2022 Nov; 78(2):329-342. PubMed ID: 35947334
[TBL] [Abstract][Full Text] [Related]
16. The marine metabolite SZ-685C induces apoptosis in primary human nonfunctioning pituitary adenoma cells by inhibition of the Akt pathway in vitro.
Wang X; Tan T; Mao ZG; Lei N; Wang ZM; Hu B; Chen ZY; She ZG; Zhu YH; Wang HJ
Mar Drugs; 2015 Mar; 13(3):1569-80. PubMed ID: 25806467
[TBL] [Abstract][Full Text] [Related]
17. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
18. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
19. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
20. Exosomal hsa-miR-21-5p derived from growth hormone-secreting pituitary adenoma promotes abnormal bone formation in acromegaly.
Xiong Y; Tang Y; Fan F; Zeng Y; Li C; Zhou G; Hu Z; Zhang L; Liu Z
Transl Res; 2020 Jan; 215():1-16. PubMed ID: 31469974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
